TRINEUROSOL HP INJECTION 5ML belongs to the class of Vitamins used for the treatment and prevention of anaemias caused due to vitamin B12 deficiency. Also, it is used to treat conditions such as Tobacco amblyopia and Leber’s atrophy which results in a dimming of vision. Vitamin B12 deficiency anaemia is a condition that occurs due to low red blood cell count due to vitamin B12 deficiency.

TRINEUROSOL HP INJECTION 5ML contains Hydroxocobalamin (a synthetic form of vitamin B12) which works by providing the necessary amount of vitamin B12 to the body. 

TRINEUROSOL HP INJECTION 5ML will be administered by a healthcare professional; do not self-administer. Sometimes, TRINEUROSOL HP INJECTION 5ML may cause common side effects such as nausea, vomiting, diarrhoea, headache, dizziness, acne, itching, redness, swelling or pain at the injection site. These side effects do not require medical attention and gradually resolve over time. However, if the symptoms persist or worsen, please consult your doctor.

If you are allergic to Hydroxocobalamin or other medicines, please tell your doctor. TRINEUROSOL HP INJECTION 5ML is not recommended for the treatment of megaloblastic anaemia during pregnancy. If you are pregnant or breastfeeding, please inform your doctor before receiving TRINEUROSOL HP INJECTION 5ML. Avoid driving or operating machinery if you feel dizzy or drowsy after receiving TRINEUROSOL HP INJECTION 5ML. Your doctor may recommend regular blood tests while on treatment with TRINEUROSOL HP INJECTION 5ML. If your symptoms do not improve after several weeks of treatment with TRINEUROSOL HP INJECTION 5ML, discuss with your doctor.

TRINEUROSOL HP INJECTION 5ML contains Hydroxocobalamin used for the treatment of Addisonian pernicious anaemia, to prevent and treat other macrocytic anaemias due to vitamin B12 deficiency, Tobacco amblyopia and Leber’s atrophy, which results in a dimming of vision. It provides an essential amount of vitamin B12 to the body.

• Nausea
• Vomiting
• Diarrhoea
• Headache
• Dizziness
• Acne
• Itching, redness, swelling or pain at the injection site

If you are allergic to Hydroxocobalamin or other medicines, please tell your doctor. TRINEUROSOL HP INJECTION 5ML is not recommended for the treatment of megaloblastic anaemia during pregnancy. If you are pregnant or breastfeeding, please inform your doctor before receiving TRINEUROSOL HP INJECTION 5ML. Avoid driving or operating machinery if feel dizzy or drowsy after receiving TRINEUROSOL HP INJECTION 5ML. Your doctor may recommend regular blood tests while on treatment with TRINEUROSOL HP INJECTION 5ML. If your symptoms do not improve after several weeks of treatment with TRINEUROSOL HP INJECTION 5ML, discuss with your doctor.

Drug-Drug Interactions: TRINEUROSOL HP INJECTION 5ML may interact with antibiotics (chloramphenicol), oral contraceptives and antimetabolites (drugs used to treat tumours and blood disorders).

Drug-Food Interactions: No interactions found.

Drug-Disease Interactions: Inform your doctor if you have megaloblastic anaemia (a blood disorder that causes larger red blood cells) or have suffered from any heart problems.

• CHLORAMPHENICOL

• Eat Vitamin B12 rich foods such as liver, beef, chicken, fish, shellfish such as tuna fish, salmon, clams and trout, fortified breakfast cereal, eggs, low-fat milk, cheese and yoghurt.
• For people on a vegan diet, include tofu, nutritional yeast, fruit juice, breakfast cereals, margarine and spreads, dairy-free yoghurt and plant milk such as almond, soy, cashew, oat, and coconut milk. 
• Avoid smoking and alcohol consumption.
• Exercise regularly, and maintain a healthy lifestyle. 

Vitamin B12 deficiency anaemia: It is a condition that occurs due to low red blood cell count due to vitamin B12 deficiency. Symptoms include memory loss, numbness and tingling in the arms and legs, sore mouth and tongue, and depression.

Tobacco amblyopia: It is a condition in which poor eyesight is caused by toxins such as tobacco.

Leber’s atrophy: It is a condition which causes degeneration of the optic nerve resulting in loss of central vision.